PubRank

Daniel M Witt

Author PubWeight™ 27.85‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012 5.57
2 Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists. A meta-analysis. Thromb Haemost 2011 2.75
3 Assessment of warfarin dosing requirements after bariatric surgery in patients requiring long-term warfarin therapy. Pharmacotherapy 2013 2.02
4 Publication rates of abstracts presented by pharmacy residents at the Western States Conference. Am J Health Syst Pharm 2012 2.02
5 Delivery of optimized anticoagulant therapy: consensus statement from the Anticoagulation Forum. Ann Pharmacother 2008 1.32
6 Challenges to publishing pharmacy resident research projects from the perspectives of residency program directors and residents. Pharm Pract (Granada) 2013 1.01
7 Outcomes associated with combined antiplatelet and anticoagulant therapy. Chest 2008 0.90
8 Outpatient use of low molecular weight heparin monotherapy for first-line treatment of venous thromboembolism in advanced cancer. Oncologist 2012 0.88
9 Warfarin and antiplatelet combination use among commercially insured patients enrolled in an anticoagulation management service. Chest 2007 0.84
10 Impact of evacuated collection tube fill volume and mixing on routine coagulation testing using 2.5-ml (pediatric) tubes. Chest 2004 0.83
11 Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study. Med Care 2016 0.83
12 Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study. Pharmacotherapy 2008 0.82
13 A descriptive evaluation of warfarin use in patients receiving hospice or palliative care services. J Thromb Thrombolysis 2008 0.80
14 Warfarin monitoring in ambulatory older individuals receiving antimicrobial therapy. Pharmacotherapy 2005 0.79
15 A descriptive evaluation of unfractionated heparin use during pregnancy. J Thromb Thrombolysis 2008 0.79
16 Pilot study of a novel patient self-management program for warfarin therapy using venipuncture-acquired international normalized ratio monitoring. Pharmacotherapy 2012 0.78
17 Incidence of hemorrhage among anticoagulated patients receiving antiplatelet therapy after percutaneous coronary intervention. J Thromb Thrombolysis 2010 0.78
18 Anticoagulation control with daily low-dose vitamin k to reduce clinically adverse outcomes and international normalized ratio variability: a systematic review and meta-analysis. Pharmacotherapy 2013 0.77
19 Evaluation of venous thromboembolism risk following hospitalization. J Thromb Thrombolysis 2011 0.77
20 Thromboembolic events, recurrent bleeding and mortality after resuming anticoagulant following gastrointestinal bleeding. A meta-analysis. Thromb Haemost 2015 0.76
21 Falsely elevated international normalized ratio values in patients undergoing anticoagulation therapy: a descriptive evaluation. Chest 2007 0.76
22 Authors' reply. Pharmacotherapy 2014 0.75
23 Resumption of warfarin therapy after gastrointestinal tract bleeding: benefit or bias?--Reply. JAMA Intern Med 2013 0.75
24 Review: rivaroxaban causes less fatal bleeding, but does not reduce mortality, compared with VKAs. Ann Intern Med 2013 0.75
25 Evolution, current structure, and role of a primary care clinical pharmacy service in an integrated managed care organization. Ann Pharmacother 2013 0.75
26 Empiric warfarin dose adjustment with prednisone therapy. A randomized, controlled trial. J Thromb Thrombolysis 2011 0.75
27 Comparison of the Abilities of Summary Measures of International Normalized Ratio Control to Predict Clinically Relevant Bleeding. Circ Cardiovasc Qual Outcomes 2015 0.75
28 Analysis of unfractionated heparin dose requirements to target therapeutic anti-Xa intensity during pregnancy. Thromb Res 2009 0.75
29 A randomized controlled trial of empiric warfarin dose reduction with the initiation of doxycycline therapy. Thromb Res 2012 0.75
30 A descriptive evaluation of routine complete blood count monitoring in patients receiving anticoagulation therapy. J Thromb Thrombolysis 2005 0.75
31 Interventions aimed at improving performance on medication adherence metrics. Int J Clin Pharm 2014 0.75
32 Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study. Med Care 2017 0.75
33 Unfractionated heparin dose requirements targeting intermediate intensity antifactor Xa concentration during pregnancy. Pharmacotherapy 2010 0.75
34 Thromboembolic and bleeding outcomes of low-intensity warfarin thromboprophylaxis following elective total hip arthroplasty. Thromb Res 2013 0.75
35 An examination of the association between therapeutic anticoagulation control and glycemic control for patients with diabetes on oral anticoagulation therapy. J Thromb Thrombolysis 2005 0.75